1. Q-VAX is down to a few hundred doses until 2027
A few hundred doses. That's how much Q-VAX Australia has left, according to manufacturer CSL Seqirus, and the company says normal supply is unlikely to return until 2027.
Spread across an entire country, a few hundred doses is less a stockpile than a rumour.
CSL Seqirus puts the shortfall down to manufacturing setbacks. Beyond that, details are thin. The report doesn't say what went wrong at the plant, how the remaining doses will be allocated, or whether any stopgap is on the way. The full article sits behind a paywall, so that's everything on the public record for now.
If you vaccinate at-risk rural workers, your supply has just shrunk to almost nothing for the foreseeable future. Patients who planned to get protected before starting new work will need to hear that the wait could run well into 2027. They should hear it from you before they find out at the front desk.
The other risk is wasted effort. Booking someone in, only to discover no dose is coming, burns an appointment and the patient's goodwill.
The takeaway: Before you book anyone for Q fever vaccination, confirm with your supplier that a dose actually exists. Tell at-risk patients now that normal supply isn't expected until 2027, and watch for any word from CSL Seqirus on how the last few hundred doses will be shared out.